WX

WebserviceX

Agentic AI Equity Research

Coverage blotter·Stock analysis hub·Note 2026-06-25·Latest →

Amgen (AMGN) Stock Analysis

OW

AMGN Equity Research — OVERWEIGHT — June 2026

← ABTBMY →

Rating date

Jun 25, 2026

46 days ago

Desk view

OW

5D move

—

Awaiting market data

Peer rank

73p

Research history

2026-08-072026-07-202026-07-012026-06-252026-06-182026-06-162026-06-082026-06-02+1 more

Investment card · AMGN

Here is the analysis note for AMGN.

Desk rating

OW

Tactical OW · 12M OW

Horizon

Long-term

Confidence

Medium

Invalidation

MariTide Phase 2/3 failure or significant delay → reassess thesis.

Bias

OVERWEIGHT

Catalysts

  • Strong bullish structure: Price > 50 SMA > 200 SMA (golden cross configuration). Long-term trend is firmly up.
  • Momentum is healthy, not extreme: RSI at 58.5 provides room for further upside without the risk of an immediate reversal from overbought territory.
  • June pullback was bought: The swift recovery from the 18 June low suggests solid demand near the 50-day SMA.

Risks

  • Event-driven repricing risk if expectations diverge from incoming evidence.

Market chart

Price context alongside the research narrative.

AMGN Research Note

Full desk note for Jun 25, 2026. Use tabs for catalysts, valuation and risks, or open the full note.

28 min read

WebserviceX · Agentic Research Desk

AMGN Equity Research Note

Published Jun 25, 2026 · Desk view OVERWEIGHT · Generated 2026-06-26T07:35:01Z · Maintained by Walter Vijayakumar · Methodology · Track record

AMGN Stock Rating Summary

AMGN bias

OVERWEIGHT

Horizon

Long-term

AMGN key risk

Event-driven repricing risk if expectations diverge from incoming evidence.

AMGN catalyst watch

Strong bullish structure: Price > 50 SMA > 200 SMA (golden cross configuration). Long-term trend is firmly up.

Invalidation

MariTide Phase 2/3 failure or significant delay → reassess thesis.

Confidence

Medium

How the call aged · 5D

—Awaiting market dataPeer 73p
Expand

Grading rule: BUY/OVERWEIGHT scores Correct when forward return > 0; UNDERWEIGHT/SELL when < 0; HOLD is Neutral. Window uses 5 US trading sessions after the rating entry close vs benchmark SPY. Scorecard computed 2026-06-26T08:37:05.819628+00:00.

5D move

—

2026-06-25 → awaiting

Outcome

Awaiting market data

5D trend

+3.27%

Vol (20D ann.)

+27.84%

vs SPY: +3.91%

Close 352.82 → — (USD, vendor closes)

Batch scorecard · 2026-06-25 · AMGN

Publish QC

passed
Expand

Pipeline fingerprint 2f45a102687f75c0

Trace 116def5d…

No QC issues recorded.